Condition: Aortic Valve Replacement in Patients With Moderate Aortic Stenosis Combined With Mitral Regurgitation · Sponsor: Insel Gruppe AG, University Hospital Bern
The aim of the present study is to investigate safety and efficacy of early versus deferred aortic valve replacement in patients with moderate aortic stenosis combined with moderate mitral regurgitation.
This description comes directly from the study's public registry record.
Thomas Pilgrim, Prof. Dr. · 0041316325000 · kardio.studien@insel.ch
Bartowiak Joanna, Dr. med. · 0041316325000 · kardio.studien@insel.ch
Always discuss trial participation with your own doctor first.
| Insel Gruppe AG, Inselspital Bern | Bern, Switzerland | Recruiting |
| University Hospital Geneva (HUG) | Geneva, Switzerland | Recruiting |
| Heart Clinic Hirslanden | Zurich, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05310461